Rapid tests for: detection of antibodies to HIV-2, antibodies to HIV-1, antibodies to HIV 1/2, HIV-2 virus, HIV-1 virus, method: ICA, material: plasma, serum, whole blood, specificity: 99.75-100%, sensitivity: 99.84-100%; rapid cardiomarker tests: ICA, test cassette, for troponin (TnI), material whole blood, sensitivity from 95%, specificity from 95%

01

A communal non-commercial primary health care centre of the Bashtan city council in Mykolaiv region purchased rapid diagnostic tests. The goods were rapid tests detecting antibodies to HIV-2, HIV-1 and HIV 1/2 using the immunochromatographic assay on plasma, serum and whole blood, with specificity of 99.75-100% and sensitivity of 99.84-100%, plus rapid cardiomarker tests for troponin (TnI) on whole blood. The contract was awarded to 'EKSDIA PLUS' LLC. The award date was 11/09/2026. The estimated value was UAH 15,260.75. Bidders confirmed the goods did not originate from Russia, Belarus or Iran, and delivery was by the supplier's own transport at its expense.

02

Description

03

Recent awards

• Petrol A-95 (Euro 5), fuel card

  awarded to ТОВАРИСТВО З ОБМЕЖЕНОЮ ВІДПОВІДАЛЬНІСТЮ "ПЕТРОЛ ПАРТНЕР"

• Diluent: Z5 DN / 20 l; Lysing reagent: Z5 LB / 100 ml; Lysing reagent: Z5 LD / 500 ml; CBC-DH control material, 3.0 ml, normal level

  awarded to ТОВ "АЛЬБАМЕД"

• Поточний ремонт приміщень амбулаторії загальної практики сімейної медицини с. Явкине Баштанського району Миколаївської області

  awarded to ТОВАРИСТВО З ОБМЕЖЕНОЮ ВІДПОВІДАЛЬНІСТЮ ВИРОБНИЧЕ ОБ"ЄДНАННЯ "КАСКАД"

04

Change history

Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.

1. 11 Sep 2026 Read before bidding
   • Status: Now marked as Awarded
   • Award date: Awarded on September 11, 2026
   • Winner: Awarded to Товариство з обмеженою відповідальністю "ЕКСДІА ПЛЮС"

Follow this tender and we email you the moment it changes. Create account

05

Market context

Avg. open tender · Medical equipment & pharmaceuticals

€11,266,127

9,617 open across Europe right now

Buyer track record on Aperlena

22 notices tracked · 15 awarded